Correlation between SARS‐COV‐2 antibody screening by immunoassay and neutralizing antibody testing

BACKGROUND: The efficacy of convalescent plasma (CP), an alternative for the treatment of COVID‐19, depends on high titers of neutralizing antibodies (nAbs), but assays for quantifying nAbs are not widely available. Our goal was to develop a strategy to predict high titers of nAbs based on the resul...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Transfusion
Main Authors: Mendrone‐Junior, Alfredo, Dinardo, Carla Luana, Ferreira, Suzete Cleuza, Nishya, Anna, Salles, Nanci Alves, de Almeida Neto, Cesar, Hamasaki, Debora Toshei, Facincani, Tila, de Oliveira Alves, Lucas Bassolli, Machado, Rafael Rahal Guaragna, Araujo, Danielle Bastos, Durigon, Edison Luiz, Rocha, Vanderson, Sabino, Ester Cerdeira
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley & Sons, Inc. 2021
Assuntos:
Donor Infectious Disease Testing
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8013621/
https://ncbi.nlm.nih.gov/pubmed/33491194
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/trf.16268
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados